Negative pressure wound therapy (NPWT) — commercially known as Wound VAC — applies controlled subatmospheric pressure to a wound bed through a sealed foam or gauze dressing connected to a portable suction device. NPWT has become a cornerstone adjunct in the management of complex diabetic foot ulcers, post-surgical wounds, and pressure injuries — accelerating wound preparation for closure and reducing healing time when appropriate patient selection and wound preparation precede its application.

Mechanism of Action

NPWT promotes wound healing through multiple simultaneous mechanisms: (1) mechanical microdeformation of the wound bed stimulates fibroblast proliferation and angiogenesis through strain-induced cell signaling; (2) macrodeformation draws wound edges toward the center, reducing wound volume; (3) fluid removal eliminates chronic wound exudate containing matrix metalloproteinases (MMPs) that degrade healing growth factors; (4) increased tissue perfusion from subatmospheric pressure improves local oxygen delivery; and (5) bacterial bioburden reduction from continuous exudate removal. Standard NPWT pressures range from -75 to -125 mmHg applied continuously or intermittently.

Indications for Foot Wound NPWT

Primary indications in foot and ankle wound care include: post-surgical wound dehiscence and partial wound breakdown after foot surgery, diabetic foot ulcers with adequate perfusion (ABI >0.6) after adequate debridement, post-amputation stumps with delayed healing, exposed hardware or tendon with surrounding granulation tissue, and split-thickness skin graft recipient site bolstering to improve graft take. NPWT accelerates granulation tissue formation in preparation for flap or graft coverage and maintains wounds during staging toward definitive closure.

Contraindications and Precautions

Absolute contraindications include: untreated osteomyelitis or active wound infection (NPWT over infected tissue risks bacteremia), malignancy within the wound, exposed vessels or anastomoses, dry/ischemic necrotic tissue (eschar must be debrided before application), and non-enteric fistulae. Relative contraindications include active bleeding, anticoagulation, and wounds with inadequate perfusion (ABI <0.4). Vascular assessment before initiating NPWT in diabetic patients is essential — NPWT does not benefit ischemic wounds and may increase metabolic demand in marginally perfused tissue.

Dressing Changes and Clinical Protocol

Standard NPWT dressing changes are performed every 48–72 hours, or more frequently for infected wounds. Wound measurement at each dressing change quantifies progress: wounds reducing 30% or more in volume by week 4 have high probability of complete healing with continued NPWT and offloading. Wounds failing to progress by 4 weeks require reassessment for concurrent osteomyelitis, vascular insufficiency, nutritional deficit, or biofilm-forming bacterial infection. Transition from NPWT to advanced wound dressings or definitive closure (flap, graft, or primary repair) is individualized to wound readiness.

Wound Care at Balance Foot & Ankle

Dr. Biernacki at Balance Foot & Ankle provides comprehensive wound care including NPWT application and management, regular wound reassessment, vascular coordination for ischemic wounds, and total contact casting for diabetic plantar ulcers. Medicare and most insurance plans cover NPWT when documentation supports medical necessity. Call (810) 206-1402 for a same-week wound care evaluation.